Myasthenia Gravis
📧 Sign up to get email alerts when something new happens for Myasthenia Gravis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-08-11Clinical Trial Update: Intravenous Immunoglobulin and Plasma Exchange in Myasthenia Gravis [Phase 4]
This Phase 4 trial evaluated intravenous immunoglobulin (IVIG) and plasma exchange for myasthenia gravis and has completed.
-
CLINICAL_TRIALS trial_result · 2010-07-30Clinical Trial Update: Efficacy and Safety Study of GB-0998 for Treatment of Generalized Myasthenia Gravis [Phase 3]
A Phase 3 efficacy and safety trial of GB-0998 for generalized myasthenia gravis has completed.
-
CLINICAL_TRIALS research · 2009-10-19Clinical Trial Update: Trial of Mycophenolic Acid Versus Azathioprine in the Treatment of Corticosteroid-refractory Myasthenia Gravis [NA]
A clinical trial comparing mycophenolic acid to azathioprine in corticosteroid-refractory myasthenia gravis; no results or status updates ar…
-
CLINICAL_TRIALS trial_result · 2009-06-03Clinical Trial Update: An Open Study for Steroid Resistant, Non-Thymectomized MG Patients [Phase 3]
Phase 3 open-label study of steroid-resistant, non-thymectomized Myasthenia Gravis patients has completed.
-
CLINICAL_TRIALS trial_result · 2008-05-26Clinical Trial Update: A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis [Phase 3]
Phase 3 trial evaluating CellCept (mycophenolate mofetil) with reduced corticosteroids in generalized myasthenia gravis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-05-23Clinical Trial Update: A Continuation Study to Assess the Effect of CellCept in Patients With Myasthenia Gravis. [Phase 3]
A Phase 3 continuation study evaluating the effect of CellCept (mycophenolate mofetil) in patients with generalized myasthenia gravis has co…